Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 373


Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OSM) in the rat brain.

Watanabe D, Yoshimura R, Khalil M, Yoshida K, Kishimoto T, Taga T, Kiyama H.

Eur J Neurosci. 1996 Aug;8(8):1630-40.


Agonistic and antagonistic variants of ciliary neurotrophic factor (CNTF) reveal functional differences between membrane-bound and soluble CNTF alpha-receptor.

Di Marco A, Gloaguen I, Demartis A, Saggio I, Graziani R, Paonessa G, Laufer R.

J Biol Chem. 1997 Sep 12;272(37):23069-75.


Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6.

Kuropatwinski KK, De Imus C, Gearing D, Baumann H, Mosley B.

J Biol Chem. 1997 Jun 13;272(24):15135-44.


Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.

Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbieri G, Pellegrini S, et al.

Science. 1994 Jan 7;263(5143):92-5.


Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.

Timmermann A, Pflanz S, Grötzinger J, Küster A, Kurth I, Pitard V, Heinrich PC, Müller-Newen G.

FEBS Lett. 2000 Feb 25;468(2-3):120-4.


Functional requirement of gp130-mediated signaling for growth and survival of mouse primordial germ cells in vitro and derivation of embryonic germ (EG) cells.

Koshimizu U, Taga T, Watanabe M, Saito M, Shirayoshi Y, Kishimoto T, Nakatsuji N.

Development. 1996 Apr;122(4):1235-42.


The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.

Nandurkar HH, Hilton DJ, Nathan P, Willson T, Nicola N, Begley CG.

Oncogene. 1996 Feb 1;12(3):585-93.


Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.

Royuela M, Ricote M, Parsons MS, García-Tuñón I, Paniagua R, de Miguel MP.

J Pathol. 2004 Jan;202(1):41-9.


Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.

Olivier C, Auguste P, Chabbert M, Lelièvre E, Chevalier S, Gascan H.

J Biol Chem. 2000 Feb 25;275(8):5648-56.


Cross-linking identifies leukemia inhibitory factor-binding protein as a ciliary neurotrophic factor receptor component.

Stahl N, Davis S, Wong V, Taga T, Kishimoto T, Ip NY, Yancopoulos GD.

J Biol Chem. 1993 Apr 15;268(11):7628-31.


Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.

Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, Cosman D.

J Biol Chem. 1996 Dec 20;271(51):32635-43.


Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.

Chevalier S, Fourcin M, Robledo O, Wijdenes J, Pouplard-Barthelaix A, Gascan H.

J Biol Chem. 1996 Jun 21;271(25):14764-72.


The soluble interleukin-6 receptor.

Rose-John S, Ehlers M, Grötzinger J, Müllberg J.

Ann N Y Acad Sci. 1995 Jul 21;762:207-20; discussion 220-1. No abstract available.


LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor.

Davis S, Aldrich TH, Stahl N, Pan L, Taga T, Kishimoto T, Ip NY, Yancopoulos GD.

Science. 1993 Jun 18;260(5115):1805-8.


Receptor recognition sites of cytokines are organized as exchangeable modules. Transfer of the leukemia inhibitory factor receptor-binding site from ciliary neurotrophic factor to interleukin-6.

Kallen KJ, Grötzinger J, Lelièvre E, Vollmer P, Aasland D, Renné C, Müllberg J, Myer zum Büschenfelde KH, Gascan H, Rose-John S.

J Biol Chem. 1999 Apr 23;274(17):11859-67.


A sweat gland-derived differentiation activity acts through known cytokine signaling pathways.

Habecker BA, Symes AJ, Stahl N, Francis NJ, Economides A, Fink JS, Yancopoulos GD, Landis SC.

J Biol Chem. 1997 Nov 28;272(48):30421-8.


Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.

Anhuf D, Weissenbach M, Schmitz J, Sobota R, Hermanns HM, Radtke S, Linnemann S, Behrmann I, Heinrich PC, Schaper F.

J Immunol. 2000 Sep 1;165(5):2535-43.

Supplemental Content

Support Center